Combination therapies with checkpoint inhibitors: What are the promising avenues? (Including discussion of 57O and 136O)

Date 15 April 2016
Event European Lung Cancer Conference 2016 (ELCC) 2016
Session ESMO-IASLC Best Abstracts: The evolving landscape of immunotherapy
Topics Anti-Cancer Agents & Biologic Therapy
Cancer Immunology and Immunotherapy
Lung and other Thoracic Tumours
Presenter Johan Vansteenkiste
Authors J.F. Vansteenkiste
  • Respiratory Oncology Unit (pulmonology)  , University Hospital KU Leuven, 3000 - Leuven/BE